94E.F Social Sentiment

Track 94E.F's AI-powered predictions, market trends, and investment insights.

94E.F AI Prediction 94E.F StockTwits 94E.F Reddit

Mock Tradesimulated, no real money

You don't hold 94E.F in your mock portfolio yet.

94E.F Social Sentiment

Track 94E.F's AI-powered predictions, market trends, and investment insights.

94E.F AI Prediction 94E.F StockTwits 94E.F Reddit

Evidence Stack

What Changed?

Key moves vs recent baseline (last day / last week)

Price (1d)-0.7%

Price (7d)-1.9%

Volume vs avg1.0x

Volatility vs normal0.3x

Why Now?

Plain-English summary of the biggest drivers (informational)

Risk Flags

Potential risk factors to review

Low liquidity

Avg volume 0K — may be hard to exit

Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.

Invalidation Signals

Reassess your thesis if any of these occur:

Price breaks below ~€2.92 (recent support level)

Upgrade to see the full Evidence Stack

What Changed, Why Now, and Risk Flags — available on the Investor plan and above

Get Started

94E.F AI Stock Analysis

Financial Performance

bearish

Zura Bio Limited is currently loss‑making, as indicated by its negative EPS and negative PE ratio. The magnitude of losses relative to the share price suggests the market is valuing the company primarily on future potential rather than current earnings. In the absence of positive earnings or clear profitability trends, the financial profile is weak and speculative.

Negative EPS of -0.94 indicates the company is not generating positive net income and is still in a loss‑making phase.
A PE ratio of -3.81 confirms that traditional earnings-based valuation is not applicable and highlights elevated earnings risk.
Without evidence of improving profitability ratios or revenue growth in the data provided, the financial performance leans clearly toward a higher‑risk, pre‑profit profile.

Stock Price & Technicals

bearish

The stock is trading below its 200‑day moving average and has declined 15.6% over the last month, signaling negative momentum. Trading at €3.58 versus a 200‑day moving average of €3.87 suggests a downtrend or at least a period of technical weakness. Without signs of stabilization or oversold confirmation (e.g., RSI not provided), the technical picture is tilted bearish.

Current price of €3.58 is below the 200‑day moving average of €3.87, a classic sign of a weak or downward trend.
A 15.6% decline over the last month indicates recent selling pressure and negative short‑term sentiment.
The negative PE and lack of positive earnings support mean the stock’s technical weakness is not offset by clear fundamental valuation support.

Alternative Data Signals

neutral

Alternative data show a modest digital footprint, consistent with a small, early‑stage or niche company. Web traffic is low and social media followings are small but slowly growing, which suggests limited but not deteriorating investor and stakeholder engagement. These signals are not strong enough to materially offset the financial and technical weaknesses, but they do not point to a collapse in interest either.

Estimated web traffic of 7,676 visitors per month is relatively low, implying limited brand reach and external engagement at this stage.
Twitter/X following of 101 (up 1.0% in 90 days) is very small, indicating only a modest public/investor audience and slow organic growth.
LinkedIn following of 4,981 suggests somewhat better professional and industry visibility, but still not at the scale that would independently drive strong investor interest.

Conclusion

bearish

Overall, Zura Bio Limited’s profile is bearish based on the information provided. The company is loss‑making, the stock is in a short‑term downtrend and trading below its 200‑day moving average, and alternative data show only modest engagement. Unless there is a clear catalyst for revenue growth or a path to profitability, the risk‑reward skews toward caution.

Negative earnings and valuation metrics combined with recent price weakness point to elevated downside and execution risk.
Alternative data show limited but stable interest, which is insufficient to counteract the negative financial and technical signals at this time.

AI Score

Hold

Alternative8

Fundamental6

Technical6

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.

Mock Tradesimulated, no real money

You don't hold 94E.F in your mock portfolio yet.